Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $7.09, $0.80 better than the analyst estimate of $6.29. Revenue for the quarter came in at $10.55 billion versus the consensus estimate of $9.3 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.